{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-034614","form_type":"8-K","ticker":"CTOR","cik":"0001851484","company_name":"CITIUS ONCOLOGY, INC.","filed_at":"2022-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.750143+00:00","generated_at":"2026-06-21T09:09:56.337128+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"TenX Keane Acquisition announces separate trading of ordinary shares and rights effective Dec 8, 2022","bullets":["Holders of 6,600,000 units from IPO may elect to separate shares and rights starting Dec 8.","Separated ordinary shares will trade under TENK; rights under TENKR; units continue as TENKU.","Separation requires contacting transfer agent American Stock Transfer & Trust Company.","No financial terms, business combination, or change in strategy announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-034614","json":"https://secwatch.observer/filing/0001493152-22-034614.json","markdown":"https://secwatch.observer/filing/0001493152-22-034614.md","text":"https://secwatch.observer/filing/0001493152-22-034614.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851484/000149315222034614/0001493152-22-034614-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851484/000149315222034614/from8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T09:09:56.337128+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}